3D打印全骶骨假体在全骶骨切除患者腰-髂稳定性重建中的应用

目的:评估3D打印全骶骨假体在全骶骨切除患者腰-髂稳定性重建中的应用价值。方法 :回顾性分析2015年1月～2018年12月于我中心接受全骶骨切除术的42例患者资料。根据重建方式将患者分为3组:假体重建组(14例)采用3D打印全骶骨假体重建,联合重建组(19例)采用包含前方椎体重建的联合重建方案,脊柱骨盆(SPF)重建组(9例)采用单纯SPF重建。比较三组患者的腰-髂稳定性(疼痛及运动功能评分)、内置物生存情况(内置物失败率及生存期)、手术安全性(手术时间、术中出血量及围手术期并发症发生率)。结果:术后平均随访时间为33.6±14.2个月。假体重建组手术平均耗时394.6±128.0min,术中出血量平均为3250.0±1711.4ml,共2例患者发生围手术期并发症。末次随访时,13例患者无需拐杖等辅助行走,12例患者无需使用止痛药。共4例患者发生影像学内置物失败,其中2例需行二次手术,1例因严重疼痛并伴有肿瘤复发接受二次手术,术中因假体与周围骨融合牢固而未取出假体;1例因严重疼痛及运动功能明显受损接受二次手术取出假体。假体重建组平均内置物生存期为49.3(95%CI 40.8～57.9)个月。相较于其他两组患者,假体重建组患者的腰-髂稳定性、内置物生存情况均与联合重建组相近(疼痛评分2.4±0.8 vs 2.3±0.7,P=0.59;运动功能评分2.4±0.6 vs 2.2±0.7,P=0.44;内置物失败率14.3%vs 5.3%,P=0.56;内置物生存期49.3 vs 59.4个月,P=0.28),并显著优于SPF重建组(疼痛评分2.4±0.8 vs 1.7±1.0,P=0.028;运动功能评分2.4±0.6 vs 1.3±0.7,P=0.001;内置物失败率14.3%vs 66.7%,P=0.023;内置物生存期49.3 vs 28.6个月,P=0.01),且不显著增加手术时间、术中出血及围手术期并发症发生率。结论:在全骶骨切除患者中应用3D打印全骶骨假体进行重建能够取得理想的腰-髂稳定性以及满意的内置物生存情况,同时不会增加手术风险。     

低频电刺激联合生物反馈治疗子宫切除术后盆底功能障碍的效果观察

目的 探讨低频电刺激联合生物反馈治疗(子宫全切或子宫次切)术后盆底功能障碍的临床效果。方法 选择2017年6月～2019年2月在我院诊断治疗的子宫全切或次全切术后盆底功能障碍的患者100例为研究对象,随机分为观察组与对照组,每组50例。对照组实施盆底肌功能训练,观察组实施低频电刺激治疗及生物反馈治疗。比较两组治疗前后PFDI-20评分、最大尿流率、平均尿流率、排尿时间、残余尿、盆底电生理功能。结果(1)治疗后,两组PFDI-20评分较治疗前低,差异有统计学意义(P0.05);观察组治疗后PFDI-20评分较对照组低,差异有统计学意义(P0.05)。(2)治疗后,两组最大尿流率、平均尿流率均显著提高,与治疗前比较差异有统计学意义(P0.05);两组排尿时间短于治疗前,残余尿量少于治疗前,差异有统计学意义(P0.05)。治疗后,观察组相较于对照组,排尿时间更短,残余尿量更少,差异有统计学意义(P0.05)。(3)治疗后,两组Ⅰ类肌纤维肌力、Ⅱ类肌纤维肌力均高于治疗前,差异有统计学意义(P0.05);观察组治疗后Ⅰ类肌纤维肌力、Ⅱ类肌纤维肌力优于对照组,差异有统计学意义(P0.05)。结论 低频电刺激联合生物反馈治疗子宫切除术后盆底功能障碍可显著改善盆底电生理功能,改善排尿情况,改善症状。     

Interstitial lung diseases in children

Interstitial lung disease (ILD) in children (chILD) is a heterogeneous group of rare respiratory disorders that are mostly chronic and associated with high morbidity and mortality. The pathogenesis of the various chILD is complex and the diseases share common features of inflammatory and fibrotic changes of the lung parenchyma that impair gas exchanges. The etiologies of chILD are numerous. In this review, we chose to classify them as ILD related to exposure/environment insults, ILD related to systemic and immunological diseases, ILD related to primary lung parenchyma dysfunctions and ILD specific to infancy. A growing part of the etiologic spectrum of chILD is being attributed to molecular defects. Currently, the main genetic mutations associated with chILD are identified in the surfactant genes SFTPA1, SFTPA2, SFTPB, SFTPC, ABCA3 and NKX2-1. Other genetic contributors include mutations in MARS, CSF2RA and CSF2RB in pulmonary alveolar proteinosis, and mutations in TMEM173 and COPA in specific auto-inflammatory forms of chILD. However, only few genotype-phenotype correlations could be identified so far. Herein, information is provided about the clinical presentation and the diagnosis approach of chILD. Despite improvements in patient management, the therapeutic strategies are still relying mostly on corticosteroids although specific therapies are emerging. Larger longitudinal cohorts of patients are being gathered through ongoing international collaborations to improve disease knowledge and targeted therapies. Thus, it is expected that children with ILD will be able to reach the adulthood transition in a better condition.     

妊娠期脂代谢异常与子痫前期发生的相关性研究

目的分析妊娠期脂代谢异常与子痫前期发生的关系。方法回顾性选取2019年1月至2020年1月于新疆医科大学第一附属医院产检并分娩的53例子痫前期产妇作为观察组,并选取同期医院产检并分娩的53例正常产妇作为对照组。记录两组产妇妊娠早、中、晚期的脂代谢指标,分析其与子痫前期发生的关系。结果两组早、中、晚期的甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)水平比较,差异具有统计学意义(P<0.001);进一步两两比较发现,两组晚期TG、HDL-C、LDL-C分别与两组早期及中期比较,差异具有统计学意义(P<0.001),两组中期TC与观察组早期及对照组晚期比较,差异具有统计学意义(P<0.001),但观察组中期与晚期TC及对照组早期与中期TC比较,差异无统计学意义(P>0.05)。经Logistic回归分析结果显示,不同妊娠期脂代谢水平与子痫前期的发生有关,妊娠早、中、晚期TG、TC、LDL-C升高及HDL-C降低可能是子痫前期发生的风险因子(P<0.05);绘制受试者工作特征(ROC)曲线结果显示,妊娠早、中、晚期TG、TC、HDL-C、LDL-C水平预测子痫前期发生风险的AUC均>0.80。结论妊娠期血脂代谢水平异常与子痫前期的发生有关,可能是产妇发生子痫前期的风险因子。     

Impact of incidental parathyroidectomy and mediastinal-recurrent cellular and lymph-node dissection on parathyroid function after total thyroidectomy

ObjectivesTo determine the impact of incidental parathyroidectomy and mediastinal-recurrent cellular and lymph-node dissection on parathyroid function after total thyroidectomy.Material and methodsA single-center retrospective study was conducted for a 5-year period in a university hospital center, including 605 patients undergoing total thyroidectomy, 52 of whom had mediastinal-recurrent cellular and lymph-node dissection.EndpointsThe main endpoint was intraoperative number of parathyroid glands as predictor of parathyroid hormone (PTH) level and postoperative hypocalcemia. The secondary endpoint was the correlation between associated mediastinal-recurrent cellular and lymph-node dissection and incidental parathyroidectomy and its impact on PTH level and calcemia in the immediate postoperative period and at 1 month.Results161 patients (26.61%) showed hypocalcemia in the immediate postoperative period and 12 (1.98%) at 1 month. Mediastinal-recurrent cellular and lymph-node dissection increased incidental parathyroidectomy risk 4.6-fold. Mediastinal-recurrent cellular and lymph-node dissection was associated with a statistically “suggestive” decrease in day-1 calcemia (P = 0.03), and no significant decrease at 1 month (P = 0.52). Incidental parathyroidectomy (6.7% of cases with parathyroidectomy versus 1.3% without) did not significantly increase the rate of early hypocalcemia (P = 0.28), but was associated with a “suggestive” worsening at 1 month (P = 0.02).ConclusionHypocalcemia after total thyroidectomy is a complex, probably multifactorial issue. Systematic parathyroid gland identification is not recommended due to the increased risk of gland lesion, mainly by devascularization. Incidental parathyroidectomy may induce hypocalcemia at 1 month postoperatively (statistically “suggestive” association).     

Can I Ski Doc?: Return to Skiing Following Total Joint Arthroplasty

BackgroundCurrently, there are little data on performance, safety, or return to downhill skiing after total joint arthroplasty (TJA). This leaves surgeons with little information for patient counseling regarding skiing.MethodsAn online survey was sent to 4360 patients who had undergone at least 1 primary TJA at a single academic center over the past 10 years (4 surgeons). The survey asked patients about their prior and current skiing activity including ability level, limitations, and reoperations. Demographics, patient-reported outcomes, and reoperations were also captured through chart review. Chi-squared, analysis of variance, and t-tests were used to compare demographics and outcomes. Paired t-tests were used to compare preoperative and postoperative skiing levels.ResultsOf the 763 survey respondents, the average follow-up was 4.4 years (range 0.5-10.3). In total, 35.6% had never skied, 26.5% had not skied in the 5 years prior to surgery (remote), and 37.9% had skied in the 5 years prior to surgery (recent). Seventy percent of recent skiers returned to skiing after surgery, compared to 11.9% of remote skiers. The majority of skiers, mostly advanced, returned to their prior level. There was no difference in return rates in those with a single total hip arthroplasty vs total knee arthroplasty vs multiple TJAs. Rates of reoperation were not significantly different between patients who did and did not return to skiing.ConclusionThe majority of recent skiers were able to return to skiing after TJA at their same level without an increase in reoperation rate. Further studies are needed to determine long-term consequences of skiing after TJA.     

Monitoring testosterone levels in testosterone-treated men

Dose adjustment with transdermal testosterone preparations should recognize the variability of serum total testosterone levels between applications and over the course of 24?h. Dose adjustments are also made difficult by between-laboratory assay variability. Low SHBG with obesity and diabetes lowers the total testosterone level, and free or bioavailable testosterone may prove to be a better choice for monitoring the progress and dosing of testosterone-treated men with adult onset hypogonadism.